University of Oxford: Risk of Rare Blood Clotting Higher for COVID-19 Than for Vaccines

The University of Oxford:

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Researchers at the University of Oxford have today reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza.

The FDA and CDC better put an emergency pause on people getting infected with COVID.

Thursday, 15 April 2021